Not applicableEnrolling By InvitationNCT07052448What this trial is testingThe Efficacy of Sequential RT After Triple Therapy for uHCCWho this might be right forHepatocellular Carcinoma Fujian Provincial Hospital 35
Large-scale testing (Phase 3)WithdrawnNCT03744247What this trial is testingLenvatinib Plus PD-1 Antibody Versus Lenvtinib Alone for Advanced HCCWho this might be right forHepatocellular Carcinoma Sun Yat-sen University
Very early researchActive Not RecruitingNCT06866548What this trial is testingSafety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate CancerWho this might be right formCRPC Shanghai Changzheng Hospital 7
Early research (Phase 1)Active Not RecruitingNCT07031765What this trial is testingPeds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade GliomaWho this might be right forRecurrent High-grade GliomaGrade III AstrocytomaOligodendroglioma+3 more University of Florida 12
Large-scale testing (Phase 3)Looking for participantsNCT07549399What this trial is testingSCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RCWho this might be right forRectal AdenocarcinomaHigh-Risk CancerMSS Sixth Affiliated Hospital, Sun Yat-sen University 204
Early research (Phase 1)UnknownNCT04137900What this trial is testingSafety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced MalignanciesWho this might be right forAdvanced Unresectable Solid TumorMetastatic Solid Tumor TopAlliance Biosciences 499
Early research (Phase 1)Study completedNCT02383212What this trial is testingStudy of REGN2810 (Anti-PD-1) in Patients With Advanced MalignanciesWho this might be right forAdvanced CancerAdvanced Malignancies Regeneron Pharmaceuticals 398
Testing effectiveness (Phase 2)Active Not RecruitingNCT06673693What this trial is testingTislelizumab Combined With SBRT for the Treatment of Head and Neck Squamous Cell CarcinomaWho this might be right forHead and Neck Squamous Cell Carcinoma (HNSCC)HNSCC Sun Yat-sen University 24
Early research (Phase 1)Study completedNCT03809767What this trial is testingCS1003 in Subjects With Advanced Solid Tumors or LymphomasWho this might be right forSolid TumorLymphoma CStone Pharmaceuticals 107
Testing effectiveness (Phase 2)Looking for participantsNCT07403136What this trial is testingBecotatug Vedotin ± Anti-PD-1 in Pretreated Advanced ESCCWho this might be right forEsophageal Squamous Cell Carcinoma Fudan University 104
Testing effectiveness (Phase 2)Active Not RecruitingNCT04304209What this trial is testingPd1 Antibody Sintilimab ± Chemoradiotherapy for Locally Advanced Rectal CancerWho this might be right forColorectal Cancer Stage IIColorectal Cancer Stage III Sun Yat-sen University 195
Testing effectiveness (Phase 2)Study completedNCT03861793What this trial is testingA Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Alfa) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Subjects With Select Advanced or Metastatic Solid Tumors (ARTISTRY-2)Who this might be right forAdvanced Solid Tumors Mural Oncology, Inc 116
Testing effectiveness (Phase 2)UnknownNCT03113266What this trial is testingSafety and Efficacy of Toripalimab for Patients With Locally Advanced or Metastatic Bladder Urothelial CarcinomaWho this might be right forBladder Urothelial Carcinoma Shanghai Junshi Bioscience Co., Ltd. 370
Testing effectiveness (Phase 2)Looking for participantsNCT06462053What this trial is testingShort-course Radiotherapy Combined With CAPOX and PD-1 Antibody Versus Long-course Chemoradiotherapy Combined With CAPOX for Early Low-lying Rectal CancerWho this might be right forEarly Low Rectal Cancer Fudan University 134
Testing effectiveness (Phase 2)Looking for participantsNCT06683846What this trial is testingIvonescimab in the Treatment of Multiple Advanced TumorsWho this might be right forPheochromocytoma/ParagangliomaRhabdomyosarcomaPaget Disease, Extramammary+16 more Fudan University 400
Large-scale testing (Phase 3)Looking for participantsNCT06857175What this trial is testingA Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Urothelial Carcinoma(PANKU-Bladder01)Who this might be right forUrothelial Carcinoma Sichuan Baili Pharmaceutical Co., Ltd. 508
Testing effectiveness (Phase 2)UnknownNCT03638297What this trial is testingPD-1 Antibody Combined With COX Inhibitor in MSI-H/dMMR or High TMB Colorectal CancerWho this might be right forColorectal Cancer Sun Yat-sen University 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06691594What this trial is testingNeoadjuvant Treatment of Triple-Negative Breast Cancer with Stereotactic Radiotherapy, PD-1 Monoclonal Antibody, and ChemotherapyWho this might be right forBreast Cancer Invasive Cancer Institute and Hospital, Chinese Academy of Medical Sciences 20
Testing effectiveness (Phase 2)Looking for participantsNCT04908566What this trial is testingImmune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction AdenocarcinomaWho this might be right forLocally Advanced Gastric Adenocarcinoma Tianjin Medical University Cancer Institute and Hospital 124
Testing effectiveness (Phase 2)Active Not RecruitingNCT05329766What this trial is testingA Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract MalignanciesWho this might be right forGastrointestinal Tract Malignancies Arcus Biosciences, Inc. 332